Nimodipine en es it fr

Nimodipine Brand names, Nimodipine Analogs

Nimodipine Brand Names Mixture

  • No information avaliable

Nimodipine Chemical_Formula


Nimodipine RX_link

Nimodipine fda sheet

Nimodipine FDA

Nimodipine msds (material safety sheet)

Nimodipine Synthesis Reference

No information avaliable

Nimodipine Molecular Weight

418.44 g/mol

Nimodipine Melting Point

No information avaliable

Nimodipine H2O Solubility

No information avaliable

Nimodipine State


Nimodipine LogP


Nimodipine Dosage Forms


Nimodipine Indication

For the treatment of subarachnoid bleeding.

Nimodipine Pharmacology

Nimodipine belongs to the class of pharmacological agents known as calcium channel blockers. Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured congenital aneurysms who are in good neurological condition post-ictus (e.g., Hunt and Hess Grades I-III). The contractile processes of smooth muscle cells are dependent upon calcium ions, which enter these cells during depolarization as slow ionic transmembrane currents. Nimodipine inhibits calcium ion transfer into these cells and thus inhibits contractions of vascular smooth muscle. In animal experiments, nimodipine had a greater effect on cerebral arteries than on arteries elsewhere in the body perhaps because it is highly lipophilic, allowing it to cross the blood brain barrier.

Nimodipine Absorption

No information avaliable

Nimodipine side effects and Toxicity

No information avaliable

Nimodipine Patient Information

No information avaliable

Nimodipine Organisms Affected

Humans and other mammals